Leading Hospital Network to Invest Rs 250 Crore in Cutting-Edge Oncology Centre with India’s First Proton Therapy System
The proposed oncology centre, to be established in Hyderabad by FY 2028, aims to enhance access to Proton Beam Therapy, a state-of-the-art cancer treatment.
Apollo Hospitals Ltd is set to revolutionize cancer treatment in India with the commissioning of a Comprehensive Oncology Centre, featuring the country’s first Proteus One Proton System. This advanced facility, along with ancillary equipment, will be developed over the next three years with an investment of Rs 250 crore.
Expansion Details
The proposed oncology centre, to be established in Hyderabad by FY 2028, aims to enhance access to Proton Beam Therapy, a state-of-the-art cancer treatment. Currently, the company’s Chennai Proton Centre has the capacity to treat 850 patients annually, with over 500 patients undergoing treatment each year. The new facility will increase capacity by an additional 350 patients per annum.
The investment of Rs 250 crore will be funded entirely through internal accruals, demonstrating Apollo Hospitals' commitment to meeting the rising demand for comprehensive oncology care in India.
Financial Performance
Revenue from operations increased by 13.9 per cent YoY to Rs 5,526.9 crore, compared to Rs 4,850.6 crore in Q3 FY24. Meanwhile, Net profit surged 51.8 per cent YoY to Rs 372.3 crore, up from Rs 245.3 crore in the same quarter last year.
EBITDA (operating profit) soared 24.1 per cent YoY to Rs 761.5 crore, compared to Rs 613.7 crore in Q3 FY24. Company’s EBITDA margin expanded to 110 basis points (bps) to 13.8% in Q3FY25, from 12.7% in Q3 FY24.
The company is also progressing on its expansion strategy, aiming to add 3,512 beds over the next 3 to 4 years, starting from FY26.
DSIJ's 'Large Rhino' service recommends blue chip stocks of Large Cap companies that have leadership positions in their category. If this interests you, do download the service details here.
Stock Performance
Over the past one year, the stock has risen 0.70 per cent, outperforming the Nifty’s 1.43 per cent decline. In the last five years, the stock has delivered multibagger returns of 257.57 per cent. The company boasts a market cap of Rs 88,818 crore.
About the Company
Apollo Hospitals, India’s first corporate hospital, has been a pioneer in private healthcare and has evolved into Asia’s leading integrated healthcare provider. With a robust presence across hospitals, pharmacies, diagnostic clinics, and retail health models, the company continues to set new benchmarks in medical excellence.
Disclaimer: The article is for informational purposes only and not investment advice.